Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

Presentation ACC 2015

EMBRACE STEMI

Presenter: C. Michael Gibson

March 15, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

Video

» Interview

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

May 4, 2022

Video

» Interview

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

May 4, 2022

Video

» Interview

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

May 4, 2022

Video

» Interview

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

May 4, 2022

Video

» Interview

GIPS-IV: The Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate After St-segment Elevation Myocardial Infarction

May 4, 2022

Video

» Interview

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

May 4, 2022

Video

» Interview

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

May 4, 2022

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Video

» Interview

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

May 4, 2022

Video

» Conference Wrap-Up

ACC 2022 Day 2 Wrap-Up

April 3, 2022

Video

» Interview

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

April 3, 2022

Video

» Interview

ACC 2022: The PROTECT Trial - Very Mild Perioperative Hypothermia Versus Aggressive Warming and Myocardial Injury After Non-Cardiac Surgery

April 3, 2022

Video

» Interview

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

April 3, 2022

Advertisement

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Live From Washington: ACC 2017, Day Three

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

EMBRACE STEMI

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Updated Cumulative Results of Treatment with Mavacamten from the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients with Obstructive Hypertrophic Cardiomyopathy

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure

METEORIC-HF: The Effect of Omecamtiv Mecarbil on Exercise Tolerance In Patients with Chronic Heart Failure and Reduced Ejection Fraction

GIPS-IV: The Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate After St-segment Elevation Myocardial Infarction

EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

ACC 2022 Day 2 Wrap-Up

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

ACC 2022: The PROTECT Trial - Very Mild Perioperative Hypothermia Versus Aggressive Warming and Myocardial Injury After Non-Cardiac Surgery

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content